These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27151755)

  • 21. Efficacy of recombinant human epidermal growth factor in pressure injury healing: evidence from Chinese randomized controlled trials.
    Ge MW; Hu FH; Jia YJ; Tang W; Zhang WQ; Chen HL
    Wound Manag Prev; 2024 Mar; 70(1):. PubMed ID: 38608161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional and perilesional application of an epidermal growth factor (Heberprot-P®) in diabetic foot ulcers. Part one.
    Montequin JF; Bonachea LS; Acosta JB; Peres CV; Gutierres WS; Duarte GA
    Angiol Sosud Khir; 2018; 24(4):33-42. PubMed ID: 30531767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Topical Oxygen Therapy in Healing Dynamics of Diabetic Foot Ulcers - A Systematic Review.
    Nataraj M; Maiya AG; Karkada G; Hande M; Rodrigues GS; Shenoy R; Prasad SS
    Rev Diabet Stud; 2019; 15():74-82. PubMed ID: 31904759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
    Hajimiri M; Shahverdi S; Esfandiari MA; Larijani B; Atyabi F; Rajabiani A; Dehpour AR; Amini M; Dinarvand R
    Drug Dev Ind Pharm; 2016; 42(5):707-19. PubMed ID: 26289000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An experimental research of recombinant human epidermal growth factor on corneal wound healing].
    Zheng R; Jin X; Yang B; Li B; Li L; Xu Z; Zhu H
    Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):215-7, 14. PubMed ID: 11877194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers.
    García-Honduvilla N; Cifuentes A; Ortega MA; Pastor M; Gainza G; Gainza E; Buján J; Álvarez-Mon M
    Endocr Connect; 2018 Apr; 7(4):584-594. PubMed ID: 29592858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing.
    Henshaw FR; Boughton P; Lo L; McLennan SV; Twigg SM
    J Diabetes Res; 2015; 2015():236238. PubMed ID: 25789327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers.
    Elraiyah T; Tsapas A; Prutsky G; Domecq JP; Hasan R; Firwana B; Nabhan M; Prokop L; Hingorani A; Claus PL; Steinkraus LW; Murad MH
    J Vasc Surg; 2016 Feb; 63(2 Suppl):46S-58S.e1-2. PubMed ID: 26804368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats.
    Gainza G; Aguirre JJ; Pedraz JL; Hernández RM; Igartua M
    Eur J Pharm Sci; 2013 Nov; 50(3-4):243-52. PubMed ID: 23872142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
    Fernández-Montequín JI; Valenzuela-Silva CM; Díaz OG; Savigne W; Sancho-Soutelo N; Rivero-Fernández F; Sánchez-Penton P; Morejón-Vega L; Artaza-Sanz H; García-Herrera A; González-Benavides C; Hernández-Cañete CM; Vázquez-Proenza A; Berlanga-Acosta J; López-Saura PA;
    Int Wound J; 2009 Dec; 6(6):432-43. PubMed ID: 20051095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.
    Valenzuela-Silva CM; Tuero-Iglesias ÁD; García-Iglesias E; González-Díaz O; Del Río-Martín A; Yera Alos IB; Fernández-Montequín JI; López-Saura PA
    Diabetes Care; 2013 Feb; 36(2):210-5. PubMed ID: 22966096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
    Hajimiri M; Shahverdi S; Esfandiari MA; Larijani B; Atyabi F; Rajabiani A; Dehpour AR; Amini M; Dinarvand R
    Drug Dev Ind Pharm; 2016 May; 42(5):707-719. PubMed ID: 26266962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis.
    Shu X; Shu S; Tang S; Yang L; Liu D; Li K; Dong Z; Ma Z; Zhu Z; Din J
    Endocr J; 2018 Apr; 65(4):403-413. PubMed ID: 29353870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study on the promoting effects of recombinant human epidermal growth factor on skin wound healing in rats].
    Zheng J; Huang XY; Wei X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Sep; 21(5):379-83. PubMed ID: 16335388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Cellular Therapy for Diabetic Foot Ulcer: A Meta-Analysis of Randomized Controlled Clinical Trials.
    Zhang Y; Deng H; Tang Z
    Cell Transplant; 2017 Dec; 26(12):1931-1939. PubMed ID: 29390881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model.
    Gainza G; Bonafonte DC; Moreno B; Aguirre JJ; Gutierrez FB; Villullas S; Pedraz JL; Igartua M; Hernandez RM
    J Control Release; 2015 Jan; 197():41-7. PubMed ID: 25449803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical Administration of
    Fallah Huseini H; Yaghoobi M; Fallahi F; Boroumand F; Ezzati MH; Tabatabaei SM; Sotvan H; Ahvazi M; Badiee Aval S; Ziaee M
    Int J Low Extrem Wounds; 2024 Jun; 23(2):238-246. PubMed ID: 34719966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers.
    Liu R; Li L; Yang M; Boden G; Yang G
    Mayo Clin Proc; 2013 Feb; 88(2):166-75. PubMed ID: 23374620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
    Fernández-Montequín JI; Infante-Cristiá E; Valenzuela-Silva C; Franco-Pérez N; Savigne-Gutierrez W; Artaza-Sanz H; Morejón-Vega L; González-Benavides C; Eliseo-Musenden O; García-Iglesias E; Berlanga-Acosta J; Silva-Rodríguez R; Betancourt BY; López-Saura PA;
    Int Wound J; 2007 Dec; 4(4):333-43. PubMed ID: 17953679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.